Internal Server Error

List of Grifols's Acquisitions

lockFilter this list
Grifols has completed a total of 8 acquisitions. Peak activity occurred with 2 acquisitions in both 2021 and 2018, along with 1 acquisition in 2020. These activities spanned 9 sectors, including Immunotherapy (3 acquisitions), Oncology (2), and Neurology (2). Geographically, acquisitions have taken place in 3 countries: 5 in the United States, 2 in Spain, and 1 in Germany. Over the last five years (2020–2025), the company has averaged 0.4 acquisitions per year, with no acquisitions completed in the current calendar year. The most recent acquisition was Biotest, a developer of plasma proteins and drugs for immunology and hematology, founded in 1946 in Dreieich, finalized in September 2021.

Here's the year on year acquisition history of Grifols:

Year on year acquisition history of Grifols202120202018Acquisitions Round Date (Yearly)0123
  • Number of Total Acquisitions
Year
# Acquisitions
2021
2
2020
1
2018
2
2014
1
2012
1
2010
1

Recent acquisitions by Grifols

Grifols's most recent acquisition - Biotest is a Developer of plasma proteins and drugs for immunology and hematology, founded in 1946 and located in Dreieich. Grifols acquired it in September 2021 for a price of $*****.

Here is the list of all acquisitions by Grifols sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Sep 17, 2021
si{q
ycrp
38
791
Mar 09, 2021
cjjn
dapp
23
884
Sep 07, 2020
mgca
lrtc
66
705
Aug 01, 2018
mxlx
vdgz
62
253
Jan 26, 2018
trfg
rnmt
71
704

View the full list of acquisitions

Sign Up for Free

FAQs about Acquisitions by Grifols

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford